North Growth Management’s Zymeworks ZYME Stock Holding History

North Growth Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	46,000 +1,000	+2%	+$23.7K	0.17%	46
2025 Q4	$1.18M	Sell	45,000 -37,000	-45%	-$807K	0.19%	46
2025 Q3	$1.41M	Sell	82,000 -15,000	-15%	-$215K	0.25%	46
2025 Q2	$1.22M	Hold	97,000	–	–	0.23%	46
2025 Q1	$1.15M	Hold	97,000	–	–	0.24%	46
2024 Q4	$1.42M	Hold	97,000	–	–	0.27%	45
2024 Q3	$1.22M	Hold	97,000	–	–	0.23%	46
2024 Q2	$825K	Hold	97,000	–	–	0.16%	44
2024 Q1	$1.02M	Hold	97,000	–	–	0.19%	45
2023 Q4	$1.01M	Hold	97,000	–	–	0.21%	46
2023 Q3	$614K	Sell	97,000 -23,000	-19%	-$170K	0.14%	48
2023 Q2	$1.04M	Hold	120,000	–	–	0.21%	47
2023 Q1	$1.09M	Buy	120,000 +45,000	+60%	+$392K	0.23%	44
2022 Q4	$591K	Hold	75,000	–	–	0.13%	44
2022 Q3	$462K	Hold	75,000	–	–	0.12%	45
2022 Q2	$399K	Buy	+75,000	New	+$454K	0.09%	46
2022 Q1	–	Sell	-69,000	Closed	-$1.14M	–	56
2021 Q4	$1.14M	Buy	69,000 +6,000	+10%	+$125K	0.19%	48
2021 Q3	$1.83M	Buy	63,000 +5,000	+9%	+$166K	0.32%	48
2021 Q2	$2.02M	Hold	58,000	–	–	0.33%	49
2021 Q1	$1.83M	Buy	58,000 +9,000	+18%	+$366K	0.33%	49
2020 Q4	$2.33M	Hold	49,000	–	–	0.48%	46
2020 Q3	$2.29M	Hold	49,000	–	–	0.5%	46
2020 Q2	$1.77M	Hold	49,000	–	–	0.43%	47
2020 Q1	$1.75M	Hold	49,000	–	–	0.49%	46
2019 Q4	$2.24M	Hold	49,000	–	–	0.5%	43
2019 Q3	$1.22M	Buy	+49,000	New	+$1.23M	0.29%	45

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

North Growth Management's ZYME Position: Q1 2026 in Review

North Growth Management increased its Zymeworks (ZYME) stake by 2.2% in Q1 2026, buying an estimated $23.7K and bringing the position to 46,000 shares worth $1.14M. The position accounts for 0.17% of the portfolio, ranked #46.

North Growth Management first reported a position in ZYME in Q3 2019 and has held it in 26 quarters since. The position peaked at $2.33M in Q4 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

North Growth Management held 46,000 shares of Zymeworks worth $1.14M as of Q1 2026.
North Growth Management bought 1,000 Zymeworks shares in Q1 2026, an estimated $23.7K.
Zymeworks made up 0.17% of North Growth Management's portfolio in Q1 2026, its #46 holding.
North Growth Management first reported a position in Zymeworks in Q3 2019 and has held it in 26 quarters since.
North Growth Management's Zymeworks position peaked at $2.33M in Q4 2020.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on North Growth Management's 13F filing for Q1 2026, filed 24 Apr 2026.